Suchergebnisse - "Ackland, James"

PubPharm (13)

1

Safety of Streptococcus pyogenes Vaccines : Anticipating and Overcoming Challenges for Clinical Trials and Post-Marketing Monitoring

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Asturias, E. | Excler, J. | Ackland, J. | +10

2

Fitting the reproduction number from UK coronavirus case data and why it is close to 1

enthalten in: Philosophical transactions. Series A, Mathematical, physical, and engineering sciences | 2022

von Ackland, G. | Ackland, J. | Antonioletti, M. | +1

3

Fitting the Reproduction number from UK coronavirus case data, and why it is close to 1

enthalten in: bioRxiv.org | 2021

von Ackland, G. | Ackland, J. | Antonioletti, M. | +1

4

Evolution of case fatality rates in the second wave of coronavirus in England: effects of false positives, a Variant of Concern and vaccination

enthalten in: bioRxiv.org | 2021

von Ackland, J. | Ackland, G. | Wallace, D.

5

Adolescent Tillaux Fractures : A Systematic Review of the Literature

enthalten in: Cureus | 2021

von Tak, S. | Qureshi, M. | Ackland, J. | +2

6

Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth

enthalten in: The New England journal of medicine | 2018

von Bines, J. | At Thobari, J. | Satria, C. | +19

CommentIn: Acta Paediatr. 2019 Apr;108(4):774. - PMID 30548693

7

Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults

enthalten in: Clinical and vaccine immunology : CVI | 2013

von Hayes, P. | Gilmour, J. | von Lieven, A. | +17

8

Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens : a phase I randomised Trial in HIV-uninfected Indian volunteers

enthalten in: PloS one | 2013

von Mehendale, S. | Thakar, M. | Sahay, S. | +18

9

A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults

enthalten in: PloS one | 2012

von Keefer, M. | Gilmour, J. | Hayes, P. | +22

10

Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas : implications for AIDS vaccine development using Sendai virus vectors

enthalten in: Human vaccines | 2011

von Hara, H. | Hara, H. | Hironaka, T. | +20